Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-20 1:48 pm Purchase | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management LLC | 5,881,879 15.000% | 2,000,000 (+51.52%) | View |
| 2024-01-16 10:45 am Purchase | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management LLC | 3,881,879 9.967% | 1,397,604 (+56.26%) | View |
| 2023-10-04 3:22 pm Purchase | 13G | ALDEYRA THERAPEUTICS, INC ALDX | Knoll Capital Management LLC | 3,595,916 6.100% | 3,595,916 (New Position) | View |
| 2023-06-20 11:04 am Purchase | 13G | HOOKIPA PHARMA INC HOOK | Knoll Capital Management LLC | 5,517,385 6.800% | 5,517,385 (New Position) | View |
| 2023-01-23 1:10 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Knoll Capital Management LLC | 3,450,000 7.180% | 3,450,000 (New Position) | View |
| 2021-06-14 12:58 pm Purchase | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management LLC | 2,484,275 10.400% | 742,912 (+42.66%) | View |
| 2021-02-16 2:48 pm Purchase | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management LLC | 1,741,363 8.300% | 1,741,363 (New Position) | View |
| 2020-08-14 4:13 pm Purchase | 13G | Orgenesis Inc. ORGS | Knoll Capital Management LLC | 1,316,364 5.900% | 1,316,364 (New Position) | View |
| 2020-02-14 4:15 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Knoll Capital Management LLC | 5,045,870 7.060% | 60,000 (+1.20%) | View |